The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2S)-N-[(1R)-1-(4-[(3,3-Dimethylcyclobutyl)methoxy]phenyl)-2-hydroxyethyl]-2-phenylpropanamide ID: ALA4777644
PubChem CID: 162644024
Max Phase: Preclinical
Molecular Formula: C24H31NO3
Molecular Weight: 381.52
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C[C@H](C(=O)N[C@@H](CO)c1ccc(OCC2CC(C)(C)C2)cc1)c1ccccc1
Standard InChI: InChI=1S/C24H31NO3/c1-17(19-7-5-4-6-8-19)23(27)25-22(15-26)20-9-11-21(12-10-20)28-16-18-13-24(2,3)14-18/h4-12,17-18,22,26H,13-16H2,1-3H3,(H,25,27)/t17-,22-/m0/s1
Standard InChI Key: MCIUTVHDOPIFLL-JTSKRJEESA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
20.3266 -23.6944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7393 -24.4043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1477 -23.6919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1535 -25.5599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1524 -26.3794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8604 -26.7884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5701 -26.3790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5673 -25.5563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8587 -25.1510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2734 -25.1450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9827 -25.5510 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.6888 -25.1397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3981 -25.5456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1043 -25.1344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4012 -26.3628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6858 -24.3225 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.8095 -25.5420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5152 -25.1315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5125 -24.3134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7983 -23.9077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0956 -24.3206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2704 -24.3278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5611 -23.9219 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.4444 -26.7875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.7370 -26.3783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7376 -25.5611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3169 -24.9866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1612 -24.9857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
13 15 1 6
12 16 2 0
14 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 14 1 0
10 22 1 6
22 23 1 0
5 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 2 1 0
2 28 1 0
28 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 381.52Molecular Weight (Monoisotopic): 381.2304AlogP: 4.45#Rotatable Bonds: 8Polar Surface Area: 58.56Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.08CX Basic pKa: ┄CX LogP: 4.32CX LogD: 4.32Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.71Np Likeness Score: -0.26
References 1. Rahman MT,Decker AM,Langston TL,Mathews KM,Laudermilk L,Maitra R,Ma W,Darcq E,Kieffer BL,Jin C. (2020) Design, Synthesis, and Structure-Activity Relationship Studies of (4-Alkoxyphenyl)glycinamides and Bioisosteric 1,3,4-Oxadiazoles as GPR88 Agonists., 63 (23): [PMID:33205975 ] [10.1021/acs.jmedchem.0c01581 ]